The U.S. point of care lipid test market is on a steady growth path, with its value estimated at USD 312.04 million in 2024 and projected to reach USD 553.25 million by 2034, growing at a CAGR of 5.9% over the forecast period. This surge is propelled by a combination of increasing cardiovascular disease prevalence, technological advancements in...